Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humansJeffrey Seow, Katie J. Doores|Nature Microbiology|2020Cited by 1.4k
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Katie J. Doores|Immunity|2021Cited by 167
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 SpikeCarl Graham, Katie J. Doores|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 33
Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclassesJerry C H Tam, Katie J. Doores|Cell Reports|2025Cited by 6
Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycansIsabella Huettner, Katie J. Doores|Cell Reports|2022Cited by 5